ICUDDR invites you to join this twitter chat on Opioid Use Disorder and Nutrition with expert panellists Khary Rigg, Ph.D. and Melody Chavez, MPH, RDN, LDN
The goal of
treatment
for opioid
addiction
or opioid use disorder (OUD) is remission of the disorder leading to lasting
recovery
.
Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential.
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
The coronavirus pandemic has presented a new challenge for public health services around the world.
Although scientists are working tirelessly to comprehend more about the virus, there are still many unanswered questions.
In a recent interview, Dr. Nora Volkow, who heads the National Institute on
Drug Abuse
, describes factors that may increase the risk of coronavirus causing greater harm to the infected individual.
Naloxone is a medication designed to rapidly reverse opioid overdose. It is an opioid antagonist—meaning that it binds to opioid receptors and can reverse and block the effects of other opioids. It can very quickly restore normal respiration to a person whose breathing has slowed or stopped as a result of overdosing with heroin or prescription opioid pain medications.
Delroy CS, Ifeanyichukwu AO, Rachel BA (2020) Attitudes towards Cough Syrup Abuse: A Study of Adolescents in Southwest, Nigeria. J
Addict
Behav Ther Rehabil 9:188. doi: 10.37532/jabtr.2020.9(1).188
One area of substance misuse among adolescents that is currently a problem, and has not been fully understood in the Nigerian context is the attitudes of adolescents towards cough syrup abuse. Thus, to inform policy actions for reducing cough syrup abuse among Nigerian adolescents, this study explored the attitudes of adolescents towards cough syrup abuse in two Southwest states of Nigeria, where
substance abuse
is rampant.
By a stratified sampling method, 302 adolescents (152 males, 150 females; mean age = 13.61 years, SD = 2.09) were selected from secondary schools in Lagos and Oyo states...
As the COVID-19 global crisis continues, it is vital that Opioid
Treatment
Programs (OTPs) remain stable sources of treatment for patients receiving support for opioid use disorders.
The American Association for the Treatment of Opioid Dependence (AAOTD) has written guidance designed to support opioid treatment services through the COVID-19 crisis.
The guidelines cover:
Maintaining Adequate Supplies of Medications and Other Vital Materials
Abstract | Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and
relapse
. However, successful
recovery
is possible with appropriate
treatment
, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted...
Restar AJ, Jin H, Ogunbajo A, et al. Prevalence and Risk Factors of Nonmedical Prescription Opioid Use Among Transgender Girls and Young Women. JAMA Netw Open. 2020;3(3):e201015. doi:10.1001/jamanetworkopen.2020.1015
Abstract
Importance: Nonmedical prescription opioid use is a pressing public health issue in the United States. Transgender youth, including adolescent girls and young women who were assigned male at birth and currently identify as women, female, transgender women, or another diverse gender identity along the transfeminine gender spectrum, are more likely than their cisgender peers to report illicit substance use and meet diagnostic criteria for substance use disorders. However, relatively little is known about the experiences of these populations in the current era of opioid
addiction
and...
Nalliah, R. P., Sloss, K. R., & Kenney, B. C. (2020). Association of opioid use with pain and satisfaction after dental extraction. JAMA Network Open, 3(3). doi:10.1001/jamanetworkopen.2020.0901
د اپیوایډ نسخې د 2010 څخه تر 2016 پورې د هغو خلکو په مینځ کې د غاښونو نوی پروسیجرونو لپاره 68 by ډیر شوی چې دمخه یې د اپیایډونو وړاندیز نه و کړی. دا څیړنه د غاښونو پروسیجرونو لپاره د اپیایډونو غیر ضروری وړاندیز کولو احتمال باندې ر lightا اچوی په ځانګړی توګه د هغو خلکو لپاره چې هیڅکله د دوی پروسیجر دمخه اپیایډز نه دی وړاندیز کړی. هغه کسان چې د غاښونو له استخراج وروسته د اپیایډونو وړاندیز شوی و، د هغو کسانو په پرتله چې د اپیایډونو نه دی وړاندیز شوی، د ډیر معتدل او شدید درد په شمول د درد درد راپور ورکړی، پداسې حال کې چې دواړو ډلو د ورته رضایت کچه راپور کړې. د 195 استخراجونو څخه ، 1145 اضافی نسخې...